blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1507531

EP1507531 - STABLE PHARMACEUTICAL COMPOSITIONS OF DESLORATADINE [Right-click to bookmark this link]
StatusPatent revoked
Status updated on  16.07.2010
Database last updated on 12.07.2024
Most recent event   Tooltip04.03.2011Lapse of the patent in a contracting state
New state(s): IT		published on 06.04.2011  [2011/14]
Applicant(s)For all designated states
Teva Pharmaceutical Industries Ltd
5 Basel Street
PO Box 3190
49131 Petah Tiqva / IL
[N/P]
Former [2007/02]For all designated states
Teva Pharmaceutical Industries Ltd
5 Basel Street PO Box 1390
49131 Petah Tiqva / IL
Former [2005/20]For all designated states
Teva Gyogyszergyar Reszvenytarsasag
Pallagi ut 13
4042 Debrecen / HU
Former [2005/08]For all designated states
BIOGAL GYOGYSZERGYAR RT.
Pallagi ut 13
4042 Debrecen / HU
Inventor(s)01 / TOTH, Zoltan G.
Gorgey u.4
4032 Debrecen / HU
02 / GYOLLAI, Viktor
Mikszath Kalman Str.77
4032 Debrecen / HU
03 / KOVACSNE-MEZEI, Adrienne
Karoli Gaspar Str.252
4032 Debrecen / HU
04 / SZABO, Csaba
Tozser u.1
4031 Debrecen / HU
05 / ARONHIME, Judith
Rehov Harav Maor, Iosef 5A
76217 Rehovot / IL
06 / SINGER, Claude
8/8 David Elazar
Kfar Saba 44358 / IL
 [2005/08]
Representative(s)Gallagher, Kirk James, et al
D Young & Co LLP
120 Holborn
London EC1N 2DY / GB
[N/P]
Former [2006/36]Gallagher, Kirk James, et al
D Young & Co 120 Holborn
London EC1N 2DY / GB
Former [2005/08]Clyde-Watson, Zöe
D Young & Co 120 Holborn
London EC1N 2DY / GB
Application number, filing date04720451.612.03.2004
[2005/08]
WO2004US07723
Priority number, dateUS20030454299P12.03.2003         Original published format: US 454299 P
US20030515354P28.10.2003         Original published format: US 515354 P
US20030516904P03.11.2003         Original published format: US 516904 P
US20030526339P01.12.2003         Original published format: US 526339 P
[2005/08]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2004080461
Date:23.09.2004
Language:EN
[2004/39]
Type: A2 Application without search report 
No.:EP1507531
Date:23.02.2005
Language:EN
The application published by WIPO in one of the EPO official languages on 23.09.2004 takes the place of the publication of the European patent application.
[2005/08]
Type: B1 Patent specification 
No.:EP1507531
Date:24.01.2007
Language:EN
[2007/04]
Search report(s)International search report - published on:EP28.10.2004
ClassificationIPC:A61K31/4545, A61P37/06
[2005/08]
CPC:
C07D401/04 (EP,US); A61K31/4545 (EP,US); A61P37/06 (EP)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2005/08]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
TitleGerman:STABILE PHARMAZEUTISCHE ZUSAMMENSETZUNGEN MIT DESLORATADINE[2005/08]
English:STABLE PHARMACEUTICAL COMPOSITIONS OF DESLORATADINE[2005/08]
French:COMPOSITIONS PHARMACEUTIQUES STABLES DE DESLORATADINE[2005/08]
Entry into regional phase10.11.2004National basic fee paid 
10.11.2004Designation fee(s) paid 
10.11.2004Examination fee paid 
Examination procedure10.11.2004Examination requested  [2005/08]
11.11.2004Amendment by applicant (claims and/or description)
02.09.2005Despatch of a communication from the examining division (Time limit: M06)
13.03.2006Reply to a communication from the examining division
25.08.2006Communication of intention to grant the patent
29.11.2006Fee for grant paid
29.11.2006Fee for publishing/printing paid
Opposition(s)Opponent(s)01  24.10.2007  06.11.2007  ADMISSIBLE
Quimica Sintética, S.A.
Gran Via Carlos III, 98, 7th floor
08028 Barcelona / ES
Opponent's representative
Schön, Christoph
Kroher-Strobel
Rechts- und Patentanwälte PartmbB
Bavariaring 20
80336 München / DE
 [N/P]
Former [2009/33]
Opponent(s)01  24.10.2007  06.11.2007  ADMISSIBLE
Quimica Sintética, S.A.
Gran Via Carlos III, 98, 7th floor
08028 Barcelona / ES
Opponent's representative
Schön, Christoph
Kroher.Strobel Rechts- und Patentanwälte Bavariaring 20
80336 München / DE
Former [2009/32]
Opponent(s)01  24.10.2007  06.11.2007  ADMISSIBLE
Quimica Sintética, S.A.
Gran Via Carlos III, 98, 7th floor
08028 Barcelona / ES
Former [2007/48]
Opponent(s)01  24.10.2007   
Quimica Sintética, S.A.
Gran Via Carlos III, 98, 7th floor
08028 Barcelona / ES
Opponent's representative
Henkel, Feiler & Hänzel
Patentanwälte Maximiliansplatz 21
80333 München / DE
28.03.2008Invitation to proprietor to file observations on the notice of opposition
29.09.2008Reply of patent proprietor to notice(s) of opposition
17.03.2010Despatch of communication that the patent will be revoked
27.03.2010Legal effect of revocation of patent [2010/33]
Fees paidRenewal fee
15.03.2006Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT24.01.2007
CH24.01.2007
CY24.01.2007
DK24.01.2007
EE24.01.2007
FI24.01.2007
LI24.01.2007
RO24.01.2007
SI24.01.2007
SK24.01.2007
IE12.03.2007
LU12.03.2007
MC31.03.2007
BG24.04.2007
GR25.04.2007
IT12.03.2010
HU13.03.2010
[2011/14]
Former [2011/10]AT24.01.2007
CH24.01.2007
CY24.01.2007
DK24.01.2007
EE24.01.2007
FI24.01.2007
LI24.01.2007
RO24.01.2007
SI24.01.2007
SK24.01.2007
IE12.03.2007
LU12.03.2007
MC31.03.2007
BG24.04.2007
GR25.04.2007
HU13.03.2010
Former [2010/50]AT24.01.2007
CH24.01.2007
CY24.01.2007
DK24.01.2007
EE24.01.2007
FI24.01.2007
LI24.01.2007
RO24.01.2007
SI24.01.2007
SK24.01.2007
IE12.03.2007
LU12.03.2007
MC31.03.2007
BG24.04.2007
GR25.04.2007
Former [2009/41]AT24.01.2007
CY24.01.2007
DK24.01.2007
EE24.01.2007
FI24.01.2007
RO24.01.2007
SI24.01.2007
SK24.01.2007
IE12.03.2007
LU12.03.2007
MC31.03.2007
BG24.04.2007
GR25.04.2007
Former [2009/35]AT24.01.2007
CY24.01.2007
DK24.01.2007
EE24.01.2007
FI24.01.2007
RO24.01.2007
SI24.01.2007
SK24.01.2007
IE12.03.2007
MC31.03.2007
BG24.04.2007
GR25.04.2007
Former [2009/11]AT24.01.2007
DK24.01.2007
EE24.01.2007
FI24.01.2007
RO24.01.2007
SI24.01.2007
SK24.01.2007
IE12.03.2007
MC31.03.2007
BG24.04.2007
GR25.04.2007
Former [2008/22]AT24.01.2007
DK24.01.2007
FI24.01.2007
RO24.01.2007
SI24.01.2007
SK24.01.2007
IE12.03.2007
MC31.03.2007
BG24.04.2007
GR25.04.2007
Former [2008/11]AT24.01.2007
DK24.01.2007
FI24.01.2007
RO24.01.2007
SI24.01.2007
SK24.01.2007
IE12.03.2007
MC31.03.2007
BG24.04.2007
Former [2008/04]AT24.01.2007
DK24.01.2007
FI24.01.2007
RO24.01.2007
SI24.01.2007
SK24.01.2007
BG24.04.2007
Former [2007/50]AT24.01.2007
DK24.01.2007
FI24.01.2007
SI24.01.2007
SK24.01.2007
BG24.04.2007
Former [2007/47]AT24.01.2007
DK24.01.2007
FI24.01.2007
SI24.01.2007
Former [2007/43]FI24.01.2007
Cited inInternational search[A]US4659716  (VILLANI FRANK J [US], et al) [A] * examples V,VI * * example III *;
 [A]EP0270818  (SCHERING CORP [US]) [A] * page 59, paragraph G * * page 71, paragraph E * * page 81; example 7 *;
 [A]WO9510515  (SCHERING CORP [US]) [A] * page 57, paragraph G *;
 [X]WO9901450  (SCHERING CORP [US]) [X] 1,4,6-19,21-34 * page 5, paragraph 2 - page 6, paragraph 2 * * page 15, paragraph 3 *;
 [X]US6506767  (SCHUMACHER DORIS P [US], et al) [X] 1,4,6-19,21-34 * column 1, line 45 - column 2, line 55 * * column 9, line 55 - line 61 * * claims 7-10 * * column 3, line 52 - line 66 *;
 [PA]WO03086275  (SUN PHARMACEUTICAL IND LTD [IN], et al) [PA] * page 9; example 1 *;
 [PA]WO2004012738  (GENEVA PHARMACEUTICALS INC [US], et al) [PA] * page 2, paragraph 6 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.